Ftse Mib
36.200,72
0,24%
DAX
21.394,93
-0,11%
S&P 500
6.101,24
-0,29%
NASDAQ
19.954,30
-0,50%
Bitcoin
104.615,80
-0,23%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ NewAmsterdam Pharma Company NV (NAMSW) NewAmsterdam Pharma Company NV (NAMSW) Notizie

NewAmsterdam Pharma Company NV

NAMSW
11,96
-0,47 (-3,78%)
25 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Warrant Azionario
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/1/202522:26EDGAR2Form 144 - Report of proposed sale of securities
10/1/202514:27EDGAR2Form 8-K - Current report
10/1/202514:00GLOBENewAmsterdam Pharma Highlights 2024 Achievements and..
09/1/202521:38GLOBENewAmsterdam Pharma Reports Inducement Grants Under Nasdaq..
08/1/202523:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202523:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202523:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202523:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202522:29EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/1/202523:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202523:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202523:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202423:16GLOBENewAmsterdam Pharma Announces Closing of Upsized $479.0..
13/12/202414:28EDGAR2Form 8-K - Current report
13/12/202412:33EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/12/202403:37GLOBENewAmsterdam Pharma Announces Pricing of Upsized $416.5..
12/12/202401:57EDGAR2Form S-3MEF - Registration adding securities to prior Form..
10/12/202422:48EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/12/202422:34GLOBENewAmsterdam Pharma Announces Commencement of $300 Million..
10/12/202422:01EDGAR2Form 8-K - Current report
10/12/202413:24EDGAR2Form 8-K - Current report
10/12/202413:00GLOBENewAmsterdam Pharma Announces Positive Topline Data from..
06/12/202422:01GLOBENewAmsterdam Pharma Reports Inducement Grants Under Nasdaq..
20/11/202413:07EDGAR2Form 8-K - Current report
20/11/202413:00GLOBENewAmsterdam Pharma Announces Positive Topline Data from..
18/11/202422:11EDGAR2Form 8-K - Current report
18/11/202421:20GLOBENewAmsterdam Pharma Presents Additional Data from Pivotal..
13/11/202422:23EDGAR2Form 144 - Report of proposed sale of securities
06/11/202414:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202414:00EDGAR2Form 8-K - Current report
06/11/202414:00GLOBENewAmsterdam Pharma Provides Corporate Update and Reports..
01/11/202422:26GLOBENewAmsterdam Pharma Reports Inducement Grants Under Nasdaq..
28/10/202421:30GLOBENewAmsterdam Pharma to Participate in Upcoming Medical and..
18/10/202422:51EDGAR2Form 8-K - Current report
04/10/202422:30GLOBENewAmsterdam Pharma Reports Inducement Grants Under Nasdaq..
01/10/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202423:12EDGAR2Form 144 - Report of proposed sale of securities
30/9/202423:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202422:32GLOBENewAmsterdam Pharma Reports Inducement Grants Under Nasdaq..
30/8/202414:00GLOBENewAmsterdam Pharma to Participate in Upcoming Investor..
07/8/202414:00GLOBENewAmsterdam Pharma Provides Corporate Update and Reports..
02/8/202422:01GLOBENewAmsterdam Pharma Reports Inducement Grants Under Nasdaq..
29/7/202414:00GLOBENewAmsterdam Pharma Announces Positive Topline Data from..
26/7/202422:01GLOBENewAmsterdam Pharma to Announce Topline Data from Pivotal..
18/7/202414:00GLOBENewAmsterdam Pharma Announces Appointments of Mark C...
08/7/202414:00GLOBENewAmsterdam Pharma Completes Enrollment in Pivotal Phase 3..
03/7/202422:01GLOBENewAmsterdam Pharma Reports Inducement Grants Under Nasdaq..
11/6/202414:12EDGAR2Form 8-K - Current report
11/6/202414:00GLOBENewAmsterdam Pharma Announces Issuance of Composition of..
07/6/202422:15EDGAR2Form 8-K - Current report
Apertura: 11,45 Min: 11,45 Max: 12,13
Chiusura: 12,43

La tua Cronologia

NASDAQ
NAMSW
NewAmsterdam Pharma Comp...
ASX
MGU
Magnum Mining And Explor...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network